Ditchcarbon
  • Customers
  1. Organizations
  2. Acerus Pharmaceuticals Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
CA
updated 5 months ago

Acerus Pharmaceuticals Corporation

Company website

Acerus Pharmaceuticals Corporation, often referred to simply as Acerus, is a Canadian biopharmaceutical company headquartered in Ontario, Canada. Founded in 2006, Acerus focuses on developing innovative therapeutic solutions primarily in the fields of men's health and hormone replacement therapy. The company has made significant strides with its flagship product, Natesto, a unique nasal testosterone replacement therapy that offers a convenient alternative to traditional methods. Acerus is committed to addressing unmet medical needs, positioning itself as a leader in the niche market of hormone therapies. With a strong emphasis on research and development, Acerus continues to expand its portfolio and enhance its market presence, striving to improve the quality of life for patients worldwide.

DitchCarbon Score

How does Acerus Pharmaceuticals Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Acerus Pharmaceuticals Corporation's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Acerus Pharmaceuticals Corporation's reported carbon emissions

Acerus Pharmaceuticals Corporation, headquartered in Canada, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Acerus may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Acerus Pharmaceuticals aligns with these industry trends. As the company moves forward, establishing measurable climate goals could enhance its environmental responsibility and align it with broader industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Acerus Pharmaceuticals Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Acerus Pharmaceuticals Corporation is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Acerus Pharmaceuticals Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Bgp Pharma ULC

CA
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Paladin Limited

HK
•
Real estate services (70)
Updated 14 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Hls Pharmacies, Inc.

US
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy